PreveCeutical Medical Inc.
PRVCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,175 | -$1,274 | -$1,481 | -$1,727 |
| Dep. & Amort. | $10 | $10 | $10 | $5 |
| Deferred Tax | $0 | $0 | -$22 | -$20 |
| Stock-Based Comp. | $76 | $131 | $334 | $90 |
| Change in WC | $343 | $527 | $495 | $593 |
| Other Non-Cash | $318 | $309 | $442 | $633 |
| Operating Cash Flow | -$427 | -$297 | -$223 | -$426 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | $0 | $0 | -$55 |
| Net Acquisitions | $0 | $0 | $1 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $3 |
| Investing Cash Flow | -$2 | $0 | $1 | -$53 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $248 | $94 | $218 | $137 |
| Stock Issued | $95 | $0 | -$6 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $145 | $199 | -$6 | $0 |
| Financing Cash Flow | $488 | $294 | $212 | $137 |
| Forex Effect | -$1 | -$1 | -$0 | $202 |
| Net Chg. in Cash | $58 | -$4 | -$10 | -$140 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1 | $6 | $16 | $156 |
| End Cash | $59 | $1 | $6 | $16 |
| Free Cash Flow | -$428 | -$297 | -$223 | -$482 |